Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Nucleic Acids Research|May 23, 2019
Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteinsSofie Traynor, Niels Erik Møllegaard, Mikkel G Jørgensen, et al.
Acta Oncologica (Stockholm, Sweden)|June 10, 2015
Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancerMette Pøhl, Karen Ege Olsen, Rene Holst, et al.
NPJ Precision Oncology|July 16, 2021
Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cellsMikkel G Terp, Kirstine Jacobsen, Miguel Angel Molina, et al.
The International Journal of Biochemistry & Cell Biology|November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodiesS Traynor, N D Jakobsen, M F Ebbesen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedureH J Ditzel, J M Binley, J P Moore, et al.
Stem Cells (Dayton, Ohio)|June 11, 2017
Elucidation of Altered Pathways in Tumor-Initiating Cells of Triple-Negative Breast Cancer: A Useful Cell Model System for Drug ScreeningAnne G Christensen, Sidse Ehmsen, Mikkel G Terp, et al.
Acta Oncologica (Stockholm, Sweden)|December 5, 2012
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancerChristina Bjerre, Ann Knoop, Karsten Bjerre, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|August 16, 2014
Elucidation of epithelial-mesenchymal transition-related pathways in a triple-negative breast cancer cell line model by multi-omics interactome analysisJosch K Pauling, Anne G Christensen, Richa Batra, et al.
Oncotarget|August 17, 2016
Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancerTejal Joshi, Daniel Elias, Jan Stenvang, et al.
BMC Research Notes|October 21, 2011
Analytical variables influencing the performance of a miRNA based laboratory assay for prediction of relapse in stage I non-small cell lung cancer (NSCLC)Jesper Dahlgaard, Wiktor Mazin, Thomas Jensen, et al.
Pageof 29